Influence of naturally occurring simian foamy viruses (SFVs) on SIV disease progression in the rhesus macaque (Macaca mulatta) model

Viruses

Volumn 5, Issue 6, 2013, Pages 1414-1430

  Choudhary, Anil ^a,c   Galvin, Teresa A ^a   Williams, Dhanya K ^a   Beren, Joel ^a,c   Bryant, Mark A ^b   Khan, Arifa S ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Dual retrovirus infections; Indian rhesus macaques; Preclinical AIDS model; Simian foamy virus; Simian immunodeficiency virus; SIV pathogenesis

Indexed keywords

VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DEATH; DISEASE COURSE; LYMPHOCYTE COUNT; MALE; NONHUMAN; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN FOAMY VIRUS; SURVIVAL RATE; VIRUS LOAD;

ANIMALS; ANTIBODIES, VIRAL; CD4 LYMPHOCYTE COUNT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; LONGITUDINAL STUDIES; MACACA MULATTA; PLASMA; RETROVIRIDAE INFECTIONS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN FOAMY VIRUS; SURVIVAL ANALYSIS; T-LYMPHOCYTE SUBSETS; VIRAL LOAD;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; RABBIT FIBROMA VIRUS; SIMIAN FOAMY VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84878875424     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v5061414     Document Type: Article

References (41)

1. Johnson, P.R.; Hirsch, V.M. SIV infection of macaques as a model for AIDS pathogenesis. Int. Rev. Immunol. 1992, 8, 55-63.
2. Murray, S.M.; Picker, L.J.; Axthelm, M.K.; Hudkins, K.; Alpers, C.E.; Linial, M.L. Replication in a superficial epithelial cell niche explains the lack of pathogenicity of primate foamy virus infections. J. Virol. 2008, 82, 5981-5985.
3. Falcone, V.; Leupold, J.; Clotten, J.; Urbanyi, E.; Herchenroder, O.; Spatz, W.; Volk, B.; Bohm, N.; Toniolo, A.; Neumann-Haefelin, D. et al. Sites of simian foamy virus persistence in naturally infected African green monkeys: Latent provirus is ubiquitous, whereas viral replication is restricted to the oral mucosa. Virology 1999, 257, 7-14.
4. Switzer, W.M.; Salemi, M.; Shanmugam, V.; Gao, F.; Cong, M.E.; Kuiken, C.; Bhullar, V.; Beer, B.E.; Vallet, D.; Gautier-Hion, A. et al. Ancient co-speciation of simian foamy viruses and primates. Nature 2005, 434, 376-380.
5. Liu, W.; Worobey, M.; Li, Y.; Keele, B.F.; Bibollet-Ruche, F.; Guo, Y.; Goepfert, P.A.; Santiago, M.L.; Ndjango, J.B.; Neel, C. et al. Molecular ecology and natural history of simian foamy virus infection in wild-living chimpanzees. PLoS Pathog. 2008, 4, e1000097.
6. Yu, S.F.; Stone, J.; Linial, M.L. Productive persistent infection of hematopoietic cells by human foamy virus. J. Virol. 1996, 70, 1250-1254.
7. Saib, A.; Neves, M.; Giron, M.L.; Guillemin, M.C.; Valla, J.; Peries, J.; Canivet, M. Long-term persistent infection of domestic rabbits by the human foamy virus. Virology 1997, 228, 263-268.
8. Swack, N.S.; Hsiung, G.D. Pathogenesis of simian foamy virus infection in natural and experimental hosts. Infect Immun. 1975, 12, 470-474.
9. Switzer, W.M.; Bhullar, V.; Shanmugam, V.; Cong, M.E.; Parekh, B.; Lerche, N.W.; Yee, J.L.; Ely, J.J.; Boneva, R.; Chapman, L.E. et al. Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J. Virol. 2004, 78, 2780-2789.
10. Betsem, E.; Rua, R.; Tortevoye, P.; Froment, A.; Gessain, A. Frequent and recent human acquisition of simian foamy viruses through apes' bites in central Africa. PLoS Pathog. 2011, 7, e1002306.
11. Jones-Engel, L.; Engel, G.A.; Schillaci, M.A.; Rompis, A.; Putra, A.; Suaryana, K.G.; Fuentes, A.; Beer, B.; Hicks, S.; White, R. et al. Primate-to-human retroviral transmission in Asia. Emerg. Infect. Dis. 2005, 11, 1028-1035.
12. Wolfe, N.D.; Switzer, W.M.; Carr, J.K.; Bhullar, V.B.; Shanmugam, V.; Tamoufe, U.; Prosser, A.T.; Torimiro, J.N.; Wright, A.; Mpoudi-Ngole, E. et al. Naturally acquired simian retrovirus infections in central African hunters. Lancet 2004, 363, 932-937.
13. Khan, A.S. Simian foamy virus infection in humans: Prevalence and management. Expert Rev. Anti. Infect. Ther. 2009, 7, 569-580.
14. Gessain, A.; Rua, R.; Betsem, E.; Turpin, J.; Mahieux, R. HTLV-3/4 and simian foamy retroviruses in humans: Discovery, epidemiology, cross-species transmission and molecular virology. Virology 2013, 435, 187-199.
15. Boneva, R.S.; Switzer, W.M.; Spira, T.J.; Bhullar, V.B.; Shanmugam, V.; Cong, M.E.; Lam, L.; Heneine, W.; Folks, T.M.; Chapman, L.E. Clinical and virological characterization of persistent human infection with simian foamy viruses. AIDS Res. Hum. Retrovir. 2007, 23, 1330-1337.
16. Switzer, W.M.; Garcia, A.D.; Yang, C.; Wright, A.; Kalish, M.L.; Folks, T.M.; Heneine, W. Coinfection with HIV-1 and simian foamy virus in West Central Africans. J. Infect. Dis. 2008, 197, 1389-1393.
17. Murray, S.M.; Picker, L.J.; Axthelm, M.K.; Linial, M.L. Expanded tissue targets for foamy virus replication with simian immunodeficiency virus-induced immunosuppression. J. Virol. 2006, 80, 663-670.
18. Keller, A.; Garrett, E.D.; Cullen, B.R. The Bel-1 protein of human foamy virus activates human immunodeficiency virus type 1 gene expression via a novel DNA target site. J. Virol. 1992, 66, 3946-3949.
19. Marino, S.; Kretschmer, C.; Brandner, S.; Cavard, C.; Zider, A.; Briand, P.; Isenmann, S.; Wagner, E.F.; Aguzzi, A. Activation of HIV transcription by human foamy virus in transgenic mice. Lab. Invest. 1995, 73, 103-110.
20. Schiffer, C.; Lecellier, C.H.; Mannioui, A.; Felix, N.; Nelson, E.; Lehmann-Che, J.; Giron, M.L.; Gluckman, J.C.; Saib, A.; Canque, B. Persistent infection with primate foamy virus type 1 increases human immunodeficiency virus type 1 cell binding via a Bet-independent mechanism. J. Virol. 2004, 78, 11405-11410.
21. Giraldo-Vela, J.P.; Rudersdorf, R.; Chung, C.; Qi, Y.; Wallace, L.T.; Bimber, B.; Borchardt, G.J.; Fisk, D.L.; Glidden, C.E.; Loffredo, J.T. et al. The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers. J. Virol. 2008, 82, 859-870.
22. Kaizu, M.; Borchardt, G.J.; Glidden, C.E.; Fisk, D.L.; Loffredo, J.T.; Watkins, D.I.; Rehrauer, W.M. Molecular typing of major histocompatibility complex class I alleles in the Indian rhesus macaque which restrict SIV CD8+ T cell epitopes. Immunogenetics 2007, 59, 693-703.
23. Regier, D.A.; Desrosiers, R.C. The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res. Hum. Retrovir. 1990, 6, 1221-1231.
24. Dang, Q.; Hirsch, V.M. Rapid disease progression to AIDS due to Simian immunodeficiency virus infection of macaques: Host and viral factors. Adv. Pharmacol. 2008, 56, 369-398.
25. Montefiori, D.C. Measuring HIV neutralization in a luciferase reporter gene assay. Methods Mol. Biol. 2009, 485, 395-405.
26. Bontrop, R.E.; Watkins, D.I. MHC polymorphism: AIDS susceptibility in non-human primates. Trends Immunol. 2005, 26, 227-233.
27. Muhl, T.; Krawczak, M.; Ten Haaft, P.; Hunsmann, G.; Sauermann, U. MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys. J. Immunol. 2002, 169, 3438-3446.
28. Mothe, B.R.; Weinfurter, J.; Wang, C.; Rehrauer, W.; Wilson, N.; Allen, T.M.; Allison, D.B.; Watkins, D.I. Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication. J. Virol. 2003, 77, 2736-2740.
29. Loffredo, J.T.; Maxwell, J.; Qi, Y.; Glidden, C.E.; Borchardt, G.J.; Soma, T.; Bean, A.T.; Beal, D.R.; Wilson, N.A.; Rehrauer, W.M. et al. Mamu-B*08-positive macaques control simian immunodeficiency virus replication. J. Virol. 2007, 81, 8827-8832.
30. Yant, L.J.; Friedrich, T.C.; Johnson, R.C.; May, G.E.; Maness, N.J.; Enz, A.M.; Lifson, J.D.; O'Connor, D.H.; Carrington, M.; Watkins, D.I. The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J. Virol. 2006, 80, 5074-5077.
31. Reed, J.S.; Sidney, J.; Piaskowski, S.M.; Glidden, C.E.; Leon, E.J.; Burwitz, B.J.; Kolar, H.L.; Eernisse, C.M.; Furlott, J.R.; Maness, N.J. et al. The role of MHC class I allele Mamu-A*07 during SIV(mac)239 infection. Immunogenetics 2011, 63, 789-807.
32. Heberling, R.L.; Kalter, S.S. Rapid dot-immunobinding assay on nitrocellulose for viral antibodies. J. Clin. Microbiol. 1986, 23, 109-113.
33. Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council. Guide for the Care and Use of Laboratory Animals; National Academy Press: Washington, DC, USA, 1996.
34. Khan, A.S.; Sears, J.F.; Muller, J.; Galvin, T.A.; Shahabuddin, M. Sensitive assays for isolation and detection of simian foamy retroviruses. J. Clin. Microbiol. 1999, 37, 2678-2686.
35. Newberg, M.H.; McEvers, K.J.; Gorgone, D.A.; Lifton, M.A.; Baumeister, S.H.; Veazey, R.S.; Schmitz, J.E.; Letvin, N.L. Immunodomination in the evolution of dominant epitope-specific CD8+ T lymphocyte responses in simian immunodeficiency virus-infected rhesus monkeys. J. Immunol. 2006, 176, 319-328.
36. Yuste, E.; Reeves, J.D.; Doms, R.W.; Desrosiers, R.C. Modulation of Env content in virions of simian immunodeficiency virus: Correlation with cell surface expression and virion infectivity. J. Virol. 2004, 78, 6775-6785.
37. Karber, G.A. A contribution to the collective treatment of a pharmacological experimental series. Arch. Exp. Pathol. Pharmakol. 1931, 162, 480-483.
38. Salter, R.D.; Howell, D.N.; Cresswell, P. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 1985, 21, 235-246.
39. Sodora, D.L.; Lee, F.; Dailey, P.J.; Marx, P.A. A genetic and viral load analysis of the simian immunodeficiency virus during the acute phase in macaques inoculated by the vaginal route. AIDS Res. Hum. Retrovir. 1998, 14, 171-181.
40. Dailey, P.J.; Zamroud, M.; Kelso, R.; Kolberg, J.; Urdea, M. Quantitation of Simian Immunodeficiency Virus (SIV) RNA in Plasma of Acute and Chronically Infected Rhesus Macaques Using a Branched DNA (bDNA) Signal Amplification Assay. In Proceedings of the 13th Annual Symposium Nonhuman Primate Models of AIDS, Monterey, CA, USA, 5-8 November 1995.
41. Yuste, E.; Sanford, H.B.; Carmody, J.; Bixby, J.; Little, S.; Zwick, M.B.; Greenough, T.; Burton, D.R.; Richman, D.D.; Desrosiers, R.C. et al. Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: Replication, neutralization, and survey of HIV-1-positive plasma. J. Virol. 2006, 80, 3030-3041.